Isolation Bio
Changing the paradigm of microbial discovery
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Business Model
- B2B
- Website
- isolationbio.com
- Last Round
- SeedMay 2017
- Rounds
- 1
About
Isolation Bio is a San Francisco-based life science company developing advanced high-throughput products to help researchers and companies cultivate and study bacteria from complex microbiome samples. Their flagship Prospector Discovery Platform uses microbial cultivation array technology to isolate, cultivate, and screen thousands of microcolonies in parallel, enabling rapid generation of diverse microbial libraries with a fully automated workflow. The platform adds live-cell capabilities to the high-throughput technology toolset, allowing a more comprehensive and integrated understanding of the microbiome for applications in human health, animal health, crop improvement, and environmental health.
Summary
Isolation Bio is a Biotech company based in San Francisco, United States. Its most recent funding was a Seed round in May 2017. Investors include Northpond Ventures.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
May 2017
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.